Total Payments
$14,825
2024 Payments
$1,395
Companies
71
Transactions
942
Medicare Patients
7,151
Medicare Billing
$774,406
Payment Breakdown by Category
Food & Beverage$14,552 (98.2%)
Education$228.67 (1.5%)
Other$44.60 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,552 | 935 | 98.2% |
| Education | $228.67 | 6 | 1.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44.60 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,583 | 183 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,056 | 39 | $0 (2024) |
| ABBVIE INC. | $1,032 | 84 | $0 (2024) |
| Lilly USA, LLC | $810.85 | 58 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $685.78 | 45 | $0 (2023) |
| PFIZER INC. | $584.27 | 42 | $0 (2024) |
| Astellas Pharma US Inc | $578.61 | 27 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $573.61 | 31 | $0 (2024) |
| Amgen Inc. | $491.06 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $464.98 | 39 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,395 | 76 | Lundbeck LLC ($190.15) |
| 2023 | $1,704 | 99 | AbbVie Inc. ($204.73) |
| 2022 | $2,136 | 132 | ABBVIE INC. ($343.34) |
| 2021 | $1,939 | 125 | AbbVie Inc. ($271.46) |
| 2020 | $1,089 | 68 | Novo Nordisk Inc ($399.58) |
| 2019 | $1,917 | 120 | Novo Nordisk Inc ($500.52) |
| 2018 | $2,373 | 149 | Novo Nordisk Inc ($540.17) |
| 2017 | $2,272 | 173 | Novo Nordisk Inc ($426.16) |
All Payment Transactions
942 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Automated insulin delivery system | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.17 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Endocrinology | ||||||
| 09/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Obesity | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,019 | 1,863 | $353,122 | $122,433 |
| 2022 | 27 | 1,734 | 2,415 | $380,439 | $177,674 |
| 2021 | 30 | 2,042 | 2,863 | $362,950 | $209,533 |
| 2020 | 29 | 2,356 | 3,587 | $492,549 | $264,766 |
Total Patients
7,151
Total Services
10,728
Medicare Billing
$774,406
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 253 | 514 | $154,200 | $36,467 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 209 | 586 | $71,437 | $34,469 | 48.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 138 | 146 | $25,420 | $12,318 | 48.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 123 | $20,119 | $10,980 | 54.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 55 | $19,250 | $5,907 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 87 | $19,575 | $4,019 | 20.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 34 | $9,845 | $3,973 | 40.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $5,185 | $3,450 | 66.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 100 | $6,398 | $3,372 | 52.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 47 | 47 | $5,553 | $2,682 | 48.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $2,640 | $1,647 | 62.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 23 | 23 | $8,625 | $1,623 | 18.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 32 | 33 | $2,310 | $653.67 | 28.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 16 | $890.00 | $480.16 | 54.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 30 | $1,200 | $247.68 | 20.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 20 | 28 | $280.00 | $95.48 | 34.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 12 | 13 | $195.00 | $47.34 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 257 | 515 | $113,490 | $39,874 | 35.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 188 | 197 | $53,015 | $29,528 | 55.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 177 | 376 | $37,432 | $20,408 | 54.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 157 | 157 | $34,775 | $19,424 | 55.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 93 | 196 | $28,000 | $15,324 | 54.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 85 | 110 | $24,800 | $11,892 | 48.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 136 | 138 | $21,820 | $10,916 | 50.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 117 | $19,170 | $6,619 | 34.5% |
About Dr. Gregory Cheatham, MD
Dr. Gregory Cheatham, MD is a Family Medicine healthcare provider based in Decatur, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003844754.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Cheatham, MD has received a total of $14,825 in payments from pharmaceutical and medical device companies, with $1,395 received in 2024. These payments were reported across 942 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($14,552).
As a Medicare-enrolled provider, Cheatham has provided services to 7,151 Medicare beneficiaries, totaling 10,728 services with total Medicare billing of $774,406. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Hospitalist
- Location Decatur, AL
- Active Since 06/30/2006
- Last Updated 10/02/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1003844754
Products in Payments
- Ozempic (Drug) $1,141
- REXULTI (Drug) $996.04
- FARXIGA (Drug) $632.71
- XARELTO (Drug) $589.09
- Victoza (Drug) $514.81
- VRAYLAR (Drug) $431.24
- Tresiba (Drug) $399.67
- ENTRESTO (Drug) $381.43
- UBRELVY (Drug) $349.84
- TRULICITY (Drug) $347.06
- XIFAXAN (Drug) $341.20
- Kerendia (Drug) $310.44
- LYRICA (Drug) $309.08
- NURTEC ODT (Drug) $299.31
- SUBLOCADE (Drug) $254.60
- Rybelsus (Drug) $249.19
- Saxenda (Drug) $233.87
- JARDIANCE (Drug) $221.08
- Myrbetriq (Drug) $218.04
- Otezla (Drug) $194.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Decatur
Regina Wang, M.d, M.D
Family Medicine — Payments: $28,288
Family Medicine $28,288
Mr. Edwin Matthews, Md, MD
Family Medicine — Payments: $17,802
Family Medicine $17,802
Dr. David Ibrahim, M.d, M.D
Family Medicine — Payments: $17,285
Family Medicine $17,285
Chandra Armstrong, Md, MD
Family Medicine — Payments: $11,453
Family Medicine $11,453
Dr. Marlin Gill, M.d, M.D
Family Medicine — Payments: $9,373
Family Medicine $9,373
Amber Whitfield, Md, MD
Family Medicine — Payments: $8,644
Family Medicine $8,644